In order to understand the role that different SIRT1 genetic variants may have in the development and progression of obesity, and its metabolic comorbidities, could be used in conjunction with measuring SIRT1 protein levels as a risk marker and/or diagnosis of these pathologies (Martins, 2018). The gene discussed is SIRT1; the disease is obesity disorder.